Differences in expression of dpp4 in steatotic rat liver are not related to differences in the methylation of its Gene Promoter

In Vivo

Volumn 29, Issue 5, 2015, Pages 547-554

  Tarantola, Eleonora ^a   Gobbato, Sara ^a   Ferrigno, Andrea ^a   Bertone, Vittorio ^a   Capelli, Enrica ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Dipeptidyl peptidase IV; Methylation; Rat model; Steatotic liver

Indexed keywords

DIPEPTIDYL PEPTIDASE IV;

ALCOHOLIC FATTY LIVER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA EXTRACTION; DNA METHYLATION; DNA SEQUENCE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; RAT; SEQUENCE ANALYSIS; SUBCUTANEOUS FAT; ANIMAL; DISEASE MODEL; FATTY LIVER; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHENOTYPE; SEQUENCE ALIGNMENT;

ANIMALS; BASE SEQUENCE; DIPEPTIDYL PEPTIDASE 4; DISEASE MODELS, ANIMAL; DNA METHYLATION; FATTY LIVER; GENE EXPRESSION REGULATION; GENOTYPE; MALE; MOLECULAR SEQUENCE DATA; PHENOTYPE; PROMOTER REGIONS, GENETIC; RATS; SEQUENCE ALIGNMENT;

EID: 84942104682     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Chen X: Biochemical properties of recombinant prolyl dipeptidases DPP-IV and DPP8. Adv Exp Med Biol 575: 27-32, 2006.
2. Mentlein R: Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul Pept 85: 9-24, 1999.
3. Pro B and Dang NH. CD26/dipeptidyl peptidase IV and its role in cancer. Histol Histopathol a19: 1345-1351, 2004.
4. Ohnuma K, Hosono O, Dang NH and Morimoto C: Dipeptidyl peptidase in autoimmune pathophysiology. Adv Clin Chem 53: 51-84, 2011.
5. Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens DM, Eckardt K, Kaufman JM, Ryden M, Muller S, Hanisch FG, Ruige J, Arner P, Sell H and Eckel J: Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 60: 1917-1925, 2011
6. Lopez-Delgado MI, Morales M, Villanueva-Pecarrillo ML, Malaisse WJ and Valverde I: Effects of glucagon-like peptide 1 on the kinetics of glycogen synthase a in hepatocytes from normal and diabetic rats. Endocrinology 139: 2811-2817, 1998.
7. Redondo A, Trigo MV, Acitores A, Valverde I and Villanueva-Penacarrillo ML: Cell signalling of the GLP-1 action in rat liver. Mol Cell Endocrinol 204: 43-50, 2003.
8. Zhong Q, Bollag RJ, Dransfield DT, Gasalla-Herraiz J, Ding KH, Min L and Isales CM: Glucose-dependent insulinotropic peptide signaling pathways in endothelial cells. Peptides 21: 1427-1432, 2000.
9. Flatt PR: Dorothy Hodgkin Lecture 2008. Gastric inhibitory polypeptide (GIP) revisited: Anew therapeutic target for obesity diabetes? Diabet Med 25: 759-764, 2008.
10. Tarantola E, Bertone V, Milanesi G, Capelli E, Ferrigno A, Neri D, Vairetti M, Barni S and Freitas I: Dipeptidylpeptidase IV, a key enzyme for the degradation of incretins and neuropeptides: Activity and expression in the liver of lean and obese rats. Eur J Histochem 56: e41, 2012.
11. Miyazaki M, Kato M, Tanaka K, Tanaka M, Kohjima M, Nakamura K et al: Increased hepatic expression of dipeptidyl peptidase-4 in non-Alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism. Mol Med Rep 5: 729-733, 2012.
12. Schuppan D, Gorrell MD, Klein T, Mark M and Afdhal NH: The challenge of developing novel pharmacological therapies for nonalcoholic steatohepatitis. Liver Int 30: 795-808, 2010.
13. Tarantola E, Bertone V, Capelli E, Ferrigno A, Vairetti M, Cillo U, Barni S and Freitas I: Altered expression and activity of dipeptidylpeptidase-IV in the liver of a rat model of obesity. Eur J Histochem 55(suppl 1): 24, 2011.
14. Theise D: Histopathology of alcoholic liver disease. Clin Liver Dis 2: 64-67, 2013.
15. Tarantola E, Bertone V, Milanesi G, Gruppi C, Ferrigno A, Vairetti M, Barni S and Freitas I: Dipeptidylpeptidase IV activity and expression reveal decreased damage to the intrahepatic biliary tree in fatty livers submitted to subnormothermic machine-perfusion respect to conventional cold storage. Eur J Histochem 58: 176-184, 2014.
16. McGuinness C and Wesley UV: Dipeptidyl peptidase IV (DPPIV), a candidate tumor-suppressor gene in melanomas is silenced by promoter methylation. Front Biosci 13: 2435-2443, 2008.
17. Tsuji T, Sugahara K, Tsuruda K, Uemura A, Harasawa H, Hasegawa H, Hamaguchi Y, Tomonaga M, Yamada Y and Kamihira S: Clinical and oncologic implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells. Int J Hematol 80: 254-260, 2004.
18. Novelli M, Fava P, Sarda C, Ponti R, Osella-Abate S, Savoia P, Bergallo M, Lisa F, Fierro MT and Quaglino P: Blood flow cytometry in Sary syndrome: new insights on prognostic relevance and immunophenotypic changes during follow-up. Am J Clin Pathol 143: 57-69, 2015.
19. Havre PA, Abe M, Urasaki Y, Ohnuma K, Morimoto C and Dang NH: The role of CD26/dipeptidyl peptidase IV in cancer. Front Biosci 13: 1634-1645, 2008. Review.
20. Turcot V, Tchernof A, Deshaies Y, Pusse L, Bisle A, Marceau P, Hould FS, Lebel S and Vohl MC: Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome. Diabetol Metab Syndr 5: 4, 2013.
21. Itou M, Kawaguchi T, Taniguchi E and Sata M: Dipeptidyl peptidase-4: A key player in chronic liver disease. World J Gastroenterol 19: 2298-2306, 2013.
22. Sell H, Bler M, Kling N, Schlich R, Willems M, Ruppe F, Knoefel WT, Dietrich A, Fielding BA, Arner P, Frayn KN and Eckel J: Adipose dipeptidylpeptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro. Diabetes Care 36: 4083-4090, 2013.